Inbeeo’s Post

💡 Is "Buy One, Give One" the future of pharmaceutical equity pricing? Marie-Stella-Maris (B Corp) uses this model to fund clean water initiatives. Could pharma adopt a similar approach to balance Global Pharmaceutical Pricing and ESG objectives? In our latest blog, we explore how pharma companies can align commercial sustainability with equitable access, drawing lessons from outside the industry. 👉 Read more: https://lnkd.in/e7AAYbKX Are you aiming to align your #Market Access and #ESG goals while expanding global access? Let’s explore how to strategically balance commercial sustainability with equitable access in your market access initiatives. Feel free to connect to start the conversation! Inbeeo #lifesciences #pharmaceuticals #marketacces #patientaccess #globalhealth #accesstomedicines #drugpricing #equitypricing

📣 Our companies GSK #GSKBelgium J&J Innovative Medicine Belgium Pfizer UCB were invited at a round table at PWC to discuss the power of allies and the future of Belgium's biopharma 💉 💊 . Belgium has made significant efforts to create an attractive climate for investments, and has become the #healthvalley #biotechvalley of tomorrow. We shouldn’t resign, as the sector is an essential part of the Belgian economy, but the international competition to attract investments is increasing. In order to strengthen and progress the sector’s competitiveness, HST firmly believes that several measures are necessary. This includes the preservation of the bioplatform with the authorities, effective utilisation of health data and finding middle ground between regulation and innovation. The biopharma sector does not operate in isolation but collaborates with the whole ecosystem. Hence, HST calls for government participation in issues that involve multiple sectors, industries and stakeholders. This is crucial to ensure the sustained success of Belgium’s healthcare industry on the global stage. Please read the report for more information. #innovation #belgium #healthbiotechvalley Emmanuel Amory Jan Van der Goten Xavier Hormaechea An Van Gerven Cristelle Noirhomme Marleen Hoebus Kathleen Commers Caroline L. Elisabeth Van Damme Gaëlle David Charline Desmecht

Maximise the value of your assets by embracing a future-focused approach to early commercialisation with Uptake’s new ‘Future Now’ Inspiration Pack. https://lnkd.in/e9C7kZPs  You’ll discover three insightful articles by Uptake’s pharmaceutical early commercialisation experts—Jo Lopez, Deborah Lough, and Simon Turner. Dive into: - Leveraging strategic foresight to shape tomorrow’s success  - Seven steps for cohesive strategic lifecycle planning  - Key focus areas for effective early collaboration to drive impactful patient outcomes Go beyond the articles to uncover Uptake’s essential ingredients for early commercialisation success. Learn how we collaborate with global pharmaceutical leaders to inspire exceptional outcomes, confidently shaping the future through proactive pressure testing. Take the first step toward a thriving future today:  https://lnkd.in/e9C7kZPs  #Pharma #EarlyCommercialisation #Healthcare #Consultancy 

In the latest edition, Most Visionary People Transforming Pharma and Life Sciences, CIOLOOK Magazine is pleased to feature #OmerSeyan, Chief Executive Officer of Hawkary Pharmaceuticals Co., along with other dynamic visionary leaders. Read More: https://cutt.ly/dey2nxut #pharmaceutical #pharmaceuticalindustry #pharmaceuticalmanufacturing #pharmaindustry #healthcare #businessmagazine #ciolook

Pharmaceutical giants like Pfizer, Squibb, Bristol-Myers, AstraZeneca, Johnson & Johnson and Merck have been at the forefront of adopting big data initiatives in the last few years. Recent eye-opening statistics reveal that this has resulted in an increase in data usage in the industry at a rate of 25% yearly. Analytics derived from the data have been very influential in shaping the industry by helping it make crucial decisions regarding clinical trials for the creation of effective treatments. This has led to faster treatment formulations and releases across markets. Read more here: https://bit.ly/4c8GzOX #PharmaDataAnalytics #PharmaceuticalDataAnalytics

My thoughts in a new post that was published Medium. 🌟 The pharmaceutical industry is at a pivotal crossroads where soaring healthcare costs and demands for innovation are reshaping traditional investment paradigms. 💡 From precision medicine to value-based pricing, the future of pharma hinges on strategic adaptation to new market dynamics, making it crucial for stakeholders to rethink their approach to both investment and returns. #Pharma #HealthcareInnovation #IndustryTrends

In the latest edition, Most Visionary People Transforming Pharma and Life Sciences, CIOLOOK Magazine is pleased to feature #OmerSeyan, Chief Executive Officer of Hawkary Pharmaceuticals Co., along with other dynamic visionary leaders. Read More: https://cutt.ly/dey2nxut #pharmaceutical #pharmaceuticalindustry #pharmaceuticalmanufacturing #pharmaindustry #healthcare #businessmagazine #ciolook

Pharmaceutical giants like Pfizer, Squibb, Bristol-Myers, AstraZeneca, Johnson & Johnson and Merck have been at the forefront of adopting big data initiatives in the last few years. Recent eye-opening statistics reveal that this has resulted in an increase in data usage in the industry at a rate of 25% yearly. Analytics derived from the data have been very influential in shaping the industry by helping it make crucial decisions regarding clinical trials for the creation of effective treatments. This has led to faster treatment formulations and releases across markets. Read more here: https://bit.ly/4c8GzOX #PharmaDataAnalytics #PharmaceuticalDataAnalytics

𝐆𝐄𝐑𝐌𝐀𝐍𝐘- 𝐄𝐔𝐑𝐎𝐏𝐄'𝐒 𝐋𝐀𝐑𝐆𝐄𝐒𝐓 𝐏𝐇𝐀𝐑𝐌𝐀𝐂𝐄𝐔𝐓𝐈𝐂𝐀𝐋 𝐌𝐀𝐑𝐊𝐄𝐓 Germany, recognized as one of the world's most advanced healthcare markets, serves as a crucial gateway to the EU single market for global companies. With a compound annual growth rate (CAGR) of 6.4% from 2017 to 2022, Germany's pharmaceutical sector thrives, boasting a production value of $37.53 Bn in 2021. Notably, #pharmaceutical companies in Germany invested $9.44 Bn in R&D in 2021, surpassing any other European nation. Germany also leads globally in pharmaceutical exports, reaching $110.20 Bn in 2021, while allocating 12.81% of its GDP to health expenditure as of 2021. Pharma Companies in Germany are: AstraZeneca, Johnson & Johnson, Novartis, Sanofi, Boehringer Ingelheim, Eli Lilly and Company, Roche, Gilead Sciences, Merck Healthcare, Pfizer and Bristol Myers Squibb #europe #germany #healthcareindustry #pharma #market

Pharmaceutical Industry! The past 2 days,I facilitated an intense and insightful strategy workshop with a leading pharmaceutical company in Kenya. We discussed the evolving landscape of the industry,from local manufacturing advancements to digital integration and healthcare access initiatives- it's clear the sector is poised for growth and innovation. Excited to see how these strategic discussions translate into positive impact and opportunities in this dynamic space. #PharmaceuticalIndustry #Kenya #HealthcareInnovation